Chugai Pharmabody

Global Chugai News Release

Tuesday, 19 March 2019 6:00 AM

Miraca and Chugai Enter into Business Partnership Agreement for “FoundationOne® CDx Cancer Genome Profile”

Friday, 15 March 2019 7:00 AM

Chugai Files a New Drug Application for a ROS1/TRK Inhibitor Entrectinib for the Treatment of ROS1 Fusion-Positive Non-Small Cell Lung Cancer

Thursday, 14 March 2019 6:00 AM

Chugai’s Hemlibra Receives Approval for Severe Hemophilia A without Factor VIII Inhibitors from the European Commission